Therapeutic Outreach For Children, Inc Psychologist - Cognitive & Behavioral Medicare: Not Enrolled in Medicare Practice Location: 1 Farm Ln # 458, Roosevelt, NJ 08555 Phone: 609-490-0592 Fax: 888-807-7834 |
News Archive
Low-income African-American high school students with asthma who participated in a specially-designed, web-based disease management program reported fewer days and nights with symptoms, fewer school days missed, fewer days of restricted activity, and less hospitalization for asthma during a 12-month follow-up period, as compared to non-participating asthmatic students.
The first oral medication for multiple sclerosis was approved today by the Food & Drug Administration. Physicians praised the decision to approve the drug, called fingolimod, saying it would give multiple sclerosis patients new options for treatment.
The absence of a key protein may lead to infertility. Researchers at the University of Illinois at Urbana-Champaign report that experiments involving mice - to be detailed in the Proceedings of the National Academy of Sciences - indicate that the transcription factor protein C/EBPb must be present in the uterus for pregnancy to occur.
Echo Therapeutics, Inc., a company developing its needle-free Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and its Prelude SkinPrep System for transdermal drug delivery, today announced that the company has received Certificates of Registration from the United States Patent and Trademark Office for its SYMPHONY and PRELUDE trademarks, as used with Echo's tCGM system and mechanical skin ablator, respectively.
› Verified 7 days ago